Full Text
PCN27 COST-EFFECTIVENESS OF HUMAN INTERFERON-ALPHAAS ADJUVANT TREATMENT FOR PATIENTS WITH RESECTED CUTANEOUS MALIGNANT MELANOMA IN STAGE MB III

Abstract

Authors

F Kasteng R Stadler G Wagenius J Lundkvist

Back to Volume 10, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×